ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 135 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 2.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $15,943,000 | -9.0% | 11,227,729 | +12.1% | 0.00% | -25.0% |
| Q3 2016 | $17,522,000 | +7.3% | 10,012,736 | +4.8% | 0.00% | 0.0% |
| Q2 2016 | $16,332,000 | -7.3% | 9,550,942 | +6.8% | 0.00% | 0.0% |
| Q1 2016 | $17,614,000 | +5.5% | 8,941,079 | +1.7% | 0.00% | 0.0% |
| Q4 2015 | $16,700,000 | -4.9% | 8,789,588 | -4.4% | 0.00% | -20.0% |
| Q3 2015 | $17,559,000 | -57.6% | 9,193,069 | +2.9% | 0.01% | -50.0% |
| Q2 2015 | $41,452,000 | +3.4% | 8,933,517 | -2.6% | 0.01% | 0.0% |
| Q1 2015 | $40,102,000 | +41.2% | 9,176,639 | +12.1% | 0.01% | +42.9% |
| Q4 2014 | $28,395,000 | -9.2% | 8,182,986 | +9.7% | 0.01% | -22.2% |
| Q3 2014 | $31,262,000 | -31.0% | 7,461,035 | -3.5% | 0.01% | -30.8% |
| Q2 2014 | $45,298,000 | -14.2% | 7,730,062 | -7.8% | 0.01% | -18.8% |
| Q1 2014 | $52,824,000 | +11.9% | 8,384,836 | +3.9% | 0.02% | +14.3% |
| Q4 2013 | $47,194,000 | +8.7% | 8,067,289 | -2.1% | 0.01% | -6.7% |
| Q3 2013 | $43,425,000 | -20.9% | 8,239,946 | +15.5% | 0.02% | -25.0% |
| Q2 2013 | $54,912,000 | – | 7,131,487 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |